Claro Advisors LLC Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares

Claro Advisors LLC has recently enhanced its investment in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 54.8% during the third quarter, as revealed in its latest filing with the Securities and Exchange Commission (SEC). By adding an additional 495 shares, Claro Advisors LLC now holds a total of 1,398 shares in this leading medical equipment company, which are valued at approximately $687,000 as of the end of the quarter.

Other institutional investors have also adjusted their positions in Intuitive Surgical. Ullmann Wealth Partners Group LLC increased its investment by 1.6% during the same quarter, now owning 1,329 shares worth $653,000 after acquiring 21 more shares. Similarly, One Wealth Management Investment & Advisory Services LLC raised its stake by 3.4% in the second quarter, attaining 697 shares valued at approximately $310,000 after purchasing an additional 23 shares.

Daymark Wealth Partners LLC expanded its holdings in the third quarter by 0.3%, bringing its total to 7,027 shares worth approximately $3,452,000 after acquiring 24 more shares. Indiana Trust & Investment Management CO also increased its stake by 5.3% in the second quarter, now holding 500 shares valued at $222,000, following a purchase of 25 shares. Last but not least, Hoxton Planning & Management LLC boosted its stake by 4.9% in the second quarter, now owning 534 shares valued at $238,000 after a purchase of 25 shares. Overall, institutional investors and hedge funds collectively own 83.64% of Intuitive Surgical's shares.

Insider Transactions at Intuitive Surgical

In related news, insider Mark Brosius sold 2,115 shares of the company on September 12th. The shares were sold for an average price of $491.91, totaling approximately $1,040,389.65. After the transaction, Brosius retains 295 shares, currently worth around $145,113.45, marking no significant change in his overall ownership percentage. Additionally, EVP Robert Desantis sold 1,413 shares of the company on July 26th, totaling about $619,741.80. After this sale, Desantis now holds 5,506 shares valued at approximately $2,414,931.60. Collectively, insiders have sold 53,120 shares of the company valued at $25,528,753 in the last three months, with insiders holding 0.90% of the total shares.

Stock Performance of Intuitive Surgical

On the trading floor, Intuitive Surgical shares opened at $521.15. Over the past year, the stock has fluctuated between a low of $254.85 and a high of $523.34. The company’s 50-day and 200-day simple moving averages are currently $483.85 and $438.17, respectively. With a market capitalization of $184.85 billion, Intuitive Surgical has a price-to-earnings (P/E) ratio of 94.07 and a P/E growth (P/E/G) ratio of 5.40, reflecting a beta value of 1.39.

The latest quarterly earnings report for Intuitive Surgical was released on July 18th, showing earnings per share of $1.78, surpassing analysts’ estimates of $1.54. The company generated $2.01 billion in revenue for the quarter, exceeding expectations of $1.97 billion, and representing a year-over-year revenue increase of 14.5%. Analysts forecast that Intuitive Surgical will report earnings per share of 5.22 for the current fiscal year.

Analyst Ratings for Intuitive Surgical

In light of recent performance, various brokerages have shared their updated ratings for Intuitive Surgical. Truist Financial raised its target price from $520.00 to $570.00, classifying the stock as a "buy". The Goldman Sachs Group has set a price target of $604.00, while Raymond James increased its price target from $500.00 to $540.00, issuing an "outperform" rating. Leerink Partners has adjusted its price objective from $489.00 to $502.00, and Royal Bank of Canada has lifted its target from $525.00 to $555.00. From the analysis, one analyst has rated the stock as a sell, five have assigned a hold rating, and fourteen analysts have recommended buying the stock. According to MarketBeat, Intuitive Surgical currently holds an average rating of "Moderate Buy" with a consensus price target of $513.74.

Overview of Intuitive Surgical

Intuitive Surgical, Inc. is dedicated to developing, manufacturing, and marketing products that enhance the quality and accessibility of minimally invasive care both in the United States and internationally. The company's flagship product, the da Vinci Surgical System, allows for complex surgical procedures to be performed using minimally invasive techniques. Additionally, Intuitive Surgical offers the Ion endoluminal system, which expands its services beyond surgery to include diagnostic procedures, enabling less invasive biopsies in the lung.

Intuitive, Surgical, Investors